• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. FRESENIUS COMBISET BLOODLINES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. FRESENIUS COMBISET BLOODLINES Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Death (1802); Hypoxia (1918); Ventricular Fibrillation (2130); Loss Of Pulse (2562)
Event Date 04/26/2008
Event Type  Death  
Event Description
Medical records received from plaintiff's attorney reveal that during dialysis treatment, the pt was found not breathing and in cardiac arrest in the final two (2) minutes of dialysis.Cardiopulmonary resuscitation (cpr) was initiated and the automated external defibrillator was applied with no shock indicated, so cpr resumed.Emergency (911) was called.Blood was returned.Emergency medical technicians (emt) arrived and assumed responsibility for cpr.Emt applied oxygen, intubated pt, administered intravenous epinephrine, atropine and bicarbonate and converted pt into ventricular tachycardia and ventricular fibrillation.At hospital, cpr and advanced cardiac life support (acls) protocol was initiated.Pt received epinephrine, atropine, lidocaine and bicarbonate.Defibrillation was required when pt developed ventricular fibrillation and pulseless electrical activity (pea).Pt was resuscitated, admitted, diagnosed with cardiac arrest, ventricular fibrillation, pulseless electrical activity, and hypoxia.Blood pressure stabilized and continuous renal replacement therapy was initiated for aggressive ultrafiltration.Pt was maintained on three times a week intermittent hemodialysis.Pt continued on antibiotics to exclude infection concerns prior to necessary biventricular automatic implantable cardioverter defibrillator (aicd) placement for a currently malfunctioning aicd.Pt stabilized and was discharged to a long term care facility.
 
Manufacturer Narrative
Original info from the attorney alleged the pt subsequently expired from this event.Medical records confirm the pt experienced cardiac arrest during hemodialysis, was successfully resuscitated and discharged from hospital.Death records reveal pt expired six years later from the time of this event.This event was not related to the pt's death.Medical records do not indicate any causal relationship between the pt's dialysis and her death.There is no documentation in the medical that indicates pt was receiving dialysis at the time of her death.Medical records were requested for the events surrounding the pt's death.Medical records do not contain dialysis treatment records from this event for review.In addition, medical records do not contain progress notes, lab/diagnostic reports (other than those reported in this form), dialysis treatment sheets, medication records or physician orders from the hospitalization ((b)(6) 2008) for review.Serum bicarbonate levels are not available for review.There is no documentation in the medical record that indicates any causal relationship between the pt's hemodialysis and concomitant products and the cardiac arrest.Medical records reveal that this pt had a documented history of medical non-compliance.In addition, the pt has history of cardiac issues including a pacemaker placement, valve repair and valve replacements.Medical records reveal the pacemaker was malfunctioning and the cause of death as complication of renal disease.Based on the info at hand, it appears pt factors, and complex medical history with non-compliance may have contributed to the event.This is one of six device reports associated with this event.This report is being submitted as part of a system level review which will include an investigation of all potential fresenius products being used at the time of the event.Further eval of the system level investigation has not yet been completed.A follow up report will be filed upon conclusion of the investigation.
 
Manufacturer Narrative
The system level review of the 2008k device and concomitant products found no indication that the products caused or contributed in any way to the clinical event.Upon receipt of additional information, a supplemental report will be submitted.
 
Manufacturer Narrative
A review of the device history record revealed no nonconformance reports or other abnormalities during the assembly of these lots were found.The product involved met current specifications.Complaint sample is not available for evaluation to confirm the alleged product malfunction.Therefore the complaint is deemed as not confirmed.This is one of six device reports associated with this event: 2937457-2015-01282, 8030665-2015-00332, 1713747-2015-00343, 1713747-2015-999221, 1225714-2014-13508, 1225714-2014-13509.Upon receipt of additional information, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FRESENIUS COMBISET BLOODLINES
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
cd, reynosa, tamps
MX 
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
parque industrial reynos
cd, reynosa, tamps 8878 0
MX   88780
Manufacturer Contact
corie vazquez
920 winter street
waltham, MA 02451
7816999071
MDR Report Key4938095
MDR Text Key6434995
Report Number8030665-2015-00332
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional
Reporter Occupation Not Applicable
Type of Report Initial
Report Date 07/08/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/22/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received07/08/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
208K; SALINE; CARVEDIDOL; VICODIN; GRANUFLO; CARAFATE; LISINOPRIL; COUMADIN; FMC BLOODLINES; DIALYZERS; REGLAN; RENALPLEX; NATURALYTE
Patient Outcome(s) Death; Hospitalization; Life Threatening; Required Intervention;
Patient Age41 YR
Patient Weight66
-
-